Peptide-based candidate vaccine against respiratory syncytial virus

Vaccine

Volumn 23, Issue 17-18, 2005, Pages 2261-2265

  Yusibov, Vidadi ^a   Mett, Vadim ^a   Mett, Valentina ^a   Davidson, Carley ^a   Musiychuk, Konstantin ^a   Gilliam, Suzan ^b   Farese, Ann ^b   MacVittie, Thomas ^b   Mann, Dean ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

AlMV; Plant virus; RSV

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CD8 ANTIGEN; COAT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE DERIVATIVE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS PROTEIN;

ALFALFA MOSAIC VIRUS; ANIMAL EXPERIMENT; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN ENGINEERING; T LYMPHOCYTE;

EID: 14844320019     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.039     Document Type: Conference Paper

References (14)

1. W.J. Hall, C.B. Hall, and D.M. Speers Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies Ann Int Med 88 1978 203 205
2. P.L. Collins, K. Mcintosh, and R.M. Chanock Respiratory syncytial virus B.N. Fields D.M. Knipe P.M. Howley Fields virology 1996 Raven Philadelphia 1313 1351
3. C.D. Brandt, H.W. Kim, and J.O. Arrobio Epidemiology of respiratory syncytial virus infection in Washington DC. III. Composite analysis of eleven consecutive yearly epidemics Am J Epidemiol 98 1973 355 364
4. K.M. Neuzil, C. Maynard, M.R. Griffin, and P. Heagerty Winter respiratory viruses and health care use: a population-based study in the northwest United States Clin Infect Dis 37 2003 201 207
5. W. Buraphacheep, W.J. Britt, and W. Sullender Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens J Clin Microbiol 35 1997 354 357
6. A.Z. Kapikian, R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and C.E. Stewart An epidemiologic study of altered reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine Am J Epidemiol 89 1969 405 421
7. Bangham CRM, M.J. Cannon, D.T. Karzon, and B.A. Askonas Cyctotoxic T-cell response to respiratory syncytial virus in mice J Infect Dis 163 1985 687 692
8. E.J. Stott, L.A. Ball, K.K. Young, J. Furze, and G.W. Wertz Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge J Virol 60 1986 607 613
9. A.A. Haller, M. Mitiku, and M. MacPhail Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV J Gen Virol 84 2003 2153 2162
10. H. Plotnicky, C-A. Siegrist, and J-P. Aubry Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate Vaccine 21 2003 2651 2660
11. M. Iqbal, W. Lin, I. Jabbal-Gill, S.S. Davis, M.W. Steward, and L. Illum Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice Vaccine 21 2003 1478 1485
12. C. Simard, F. Nadon, and C. Seguin Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection Vaccine 15 1997 423 432
13. H. Belanger, N. Fleysh, and S. Cox Human respiratory syncytial virus vaccine antigen produced in plants FASEB J 78 2000 1213 1217
14. R.L. De Swart, T. Kuiken, and H.H. Timmerman Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection J Virol 76 2002 11561 11569